Top Markets
Coin of the day
Metsera, Inc. Metsera, Inc.

Metsera, Inc.

MTSR
Rangering i aksjer #2738
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in... Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
Aksjekurs
$70.50
Sist synkronisert: 2025-11-14
Markedsverdi
$7.33B
Endring (1 dag)
0.00%
Endring (1 år)
116.32%
Land
US
Handel Metsera, Inc. (MTSR)

Kategori

Aksjeprishistorikk for Metsera, Inc. (MTSR)
Høyeste sluttskurs: $72.34 den 2025-11-01

Laveste sluttskurs: $26.50 den 2025-01-01
Aksjeprishistorikk for Metsera, Inc. fra 2025 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -29.98%
2025 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH